Comparison of 70 mg and 35 mg isoflavone soya supplement for menopause symptoms

International Journal of Gynecology and Obstetrics

Volumn 90, Issue 2, 2005, Pages 159-160

  Jou, H J ^a,b   Ling, P Y ^a   Wu, S C ^c  

^a TAIWAN ADVENTIST HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Climacteric symptoms; Hot flashes; Isoflavone; Menopause transition

Indexed keywords

ISOFLAVONE;

ANOREXIA; ARTICLE; BREAST TENDERNESS; CLIMACTERIUM; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; EDEMA; FATIGUE; FEMALE; HEADACHE; HORMONAL THERAPY; HUMAN; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOYBEAN; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; TREATMENT OUTCOME; VASOMOTOR DISORDER;

EID: 22144432575     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2005.03.011     Document Type: Article

References (3)

1. K.K. Han, J.M. Soares, M.A. Haidar, G.R. Lima, and E.C. Baracat Benefits of soy isoflavone therapeutic regimen on menopausal symptoms Obstet Gynecol 99 2002 389 394
2. G. Scambia, D. Mango, P.G. Signorile, R.A. Angeli, C. Palena, and D. Gallo Clinical effects of a standardized soy extract in postmenopausal women: a pilot study Menopause 7 2000 105 111
3. D.H. Upmalis, R. Lobo, L. Bradley, M. Warren, F.L. Cone, and C.A. Lamia Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study Menopause 7 2000 236 242